Table 1.
DNA methylation analysis | RNAseq analysis | |||
---|---|---|---|---|
IBD-CRC [n = 11] | Sporadic CRC [n = 11] | IBD-CRC [n = 9] | Sporadic CRC [n = 8] | |
Age [mean] | 47.2 | 65.5 | 49.2 | 57.25 |
Sex [male %] | 100% | 45% | 100% | 25% |
Location | ||||
Left colon | 7 | 7 | 6 | 5 |
Right colon | 4 | 4 | 3 | 3 |
Race | ||||
Caucasian | 8 | 5 | 7 | 5 |
AA | 0 | 3 | 0 | 2 |
Unknown | 3 | 3 | 2 | 1 |
Ethnicity | ||||
Hispanic | 2 | 0 | 1 | 0 |
Tumour grade | ||||
Low | 4 | 6 | 4 | 6 |
High | 4 | 5 | 5 | 2 |
Mucinous | 4 | 1 | 4 | 0 |
Signet ring | 0 | 1 | 0 | 0 |
Tumour multiplicity | ||||
Adenocarcinoma | 3 | 0 | 3 | 0 |
Dysplasia | 5 | N/A | 4 | N/A |
PSC | 1 | 0 | 1 | 0 |
Inflammation | ||||
Quiescent | 4 | N/A | 4 | |
Mild | 1 | 1 | ||
Moderate | 4 | 3 | ||
Severe | 2 | 1 | ||
Pancolitis | 100% | N/A | 100% | N/A |
IBD, inflammatory bowel disease; CRC, colorectal cancer; AA, African American; PSC, primary sclerosing cholangitis; N/A, not available.